The NeuroCatch Platform, a subsidiary of
HealthTech Connex, offers an objective evaluation of cognitive
function, delivered in minutes at the point of care
BOSTON, June 20,
2024 /PRNewswire/ -- HealthTech Connex, a
leading organization that connects science, research and
development to product breakthroughs utilizing state-of-the-art
brain health technology, has been named the winner of a
$1 million award from the Public
Health Agency of Canada (PHAC) to
revolutionize concussion detection and recovery. A rigorous
competition, PHAC's Detecting Concussions Using Objective
Indicators Challenge awarded HealthTech Connex with the grand
prize, whose FDA-registered NeuroCatch Platform provides
clinician's with an objective cognitive assessment tool using
neurophysiological indicators. The nation-wide challenge focused on
concussions as they are a serious public health concern, impacting
millions each year, but current methods for diagnosis and recovery
often lack objectivity, leading to potential misdiagnosis and
delayed treatment.
"We are truly honored to be recognized as the winner of this
prestigious $1 million challenge,"
said Dr. Ryan D'Arcy, President and
Chief Scientific Officer of HealthTech Connex. "This achievement
underscores our commitment to innovation and our dedication to
addressing the critical issues of concussion and brain injury. With
the Government of Canada's
support, we are making great strides toward a healthier future
through our mission of positively impacting a billion brains."
Over the next two years, the $1
million grant will support further optimization of the
NeuroCatch Platform's Index of Concussion Exposure (ICE) tool,
which leverages a multidimensional data model and the power of
artificial intelligence/machine learning (AI/ML) to deliver
real-time evaluation of concussion severity. This translates into
several potential benefits for patients and healthcare
providers:
- Objective Diagnosis and Prognosis: The ICE tool will
support both diagnosing a concussion and outlining a personalized
recovery plan, all based on the initial evaluation.
- Faster Results: Unlike traditional methods, the ICE
tool will deliver results within minutes during a patient's first
visit, eliminating the need for lengthy follow-up
appointments.
- Ease of Use: Designed for user-friendliness, the
ICE tool is accessible to healthcare professionals with minimal
specialized training.
- Quantifiable Data for Personalized Care: The ICE tool
provides objective data to guide concussion treatment plans
tailored to each patient's needs and monitor their progress
effectively.
"Concussions are a widely recognized public health issue that
can have debilitating short-term and long-term effects on brain
health," said Mark Holland from the
Public Health Agency of Canada.
"Using innovative solutions, like those developed by HealthTech
Connex, we can create a more consistent approach to concussion
management."
NeuroCatch has a well-defined timeline for bringing the ICE tool
to market. Year one will focus on data collection via clinical
studies and algorithm development, aiming to achieve diagnostic and
prognostic accuracy exceeding 90%. Year two will involve verifying
the algorithms, building user-friendly software, and crafting a
graphical interface to clearly present results. Throughout this
process, NeuroCatch will leverage its established commercialization
strategies to ensure the ICE tool reaches healthcare professionals
and improves concussion management for patients.
About NeuroCatch
NeuroCatch is medical device company focused on improving brain
health. Based on science and research, the company is focused on
translating neuroscience research innovations into real-world
medical devices. The flagship product, the NeuroCatch®
Platform, is an industry-leading medical device that offers an
objective evaluation of cognitive function, which is delivered in
minutes at the point of care. The NeuroCatch Platform can provide
value at any time in the care continuum, from initial evaluation or
post-injury through ongoing treatment, with immediate results to
help guide clinical decisions and evaluate effectiveness of
interventions.
About HealthTech Connex
HealthTech Connex connects science and R&D to product
breakthroughs utilizing state-of-the-art brain health technology.
The team comprises recognized health, science, and business leaders
with extensive experience in leveraging healthcare advances fueled
by agile partnerships through its headquarters in Surrey, British Columbia. Based on the
business model MEASURE, TEST, and TREAT, the company strives to
optimize brain health through its three divisions: NeuroCatch
Inc., Centre for Neurology Studies, and Surrey
Neuroplasticity Clinic. HealthTech Connex is dedicated to deliver
translational neuroscience innovations to care sectors and
communities worldwide. More
information: healthtechconnex.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/healthtech-connex-awarded-1-million-from-the-government-of-canada-to-revolutionize-concussion-detection-and-recovery-302177682.html
SOURCE NueroCatch, Inc.